Corrigendum|Articles in Press

Corrigendum to “Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma” [Eur J Cancer 126 (2020) 93–103]

Open AccessPublished:February 27, 2023DOI:
      The authors regret that the acknowledgements section of the published paper was incomplete and should include the following statement:
      Raquel Vivet-Noguer was supported by the Institut Curie 3-i PhD Program under Marie Skłodowska-Curie Grant Agreement No 666003.
      The authors would like to apologise for any inconvenience caused.

      Linked Article